Literature DB >> 22981392

Vaccines and antibiotic resistance.

Ravi P N Mishra1, Ernesto Oviedo-Orta, Prachi Prachi, Rino Rappuoli, Fabio Bagnoli.   

Abstract

Vaccines and antibiotics have significantly contributed to improve health and also to increase the longevity of human beings. The fast-acting effect of antibiotics makes them indispensable to treat infected patients. Likewise, when the causative agent of the infection is unknown and in cases of superinfections with different species of bacteria, antibiotics appear to be the only therapeutic option. On the contrary, vaccines are usually not efficacious in people already infected and their action is generally limited to a much narrowed range of pathogens. However, vaccines have contributed to the eradication of some of the most deadly infectious agents worldwide, can generate immunity to infections lasting for several years or life-long, and are able to induce herd immunity. Nonetheless, infectious diseases are still among the leading causes of morbidity and mortality worldwide. This is mainly owing to the emergence of bacterial resistance to antibiotics and the lack of efficacious medications to treat several other infectious diseases. Development of new vaccines appears to be a promising solution to these issues. Indeed, with the advent of new discovery approaches and adjuvants, today is possible to make vaccines virtually against every pathogen. In addition, while vaccine-resistant bacteria have never been reported, accumulating literature is providing evidence that vaccination can reduce the raise of antibiotic resistant strains by decreasing their use.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981392     DOI: 10.1016/j.mib.2012.08.002

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  27 in total

1.  Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection.

Authors:  Siobhán McClean; Marc E Healy; Cassandra Collins; Stephen Carberry; Luke O'Shaughnessy; Ruth Dennehy; Áine Adams; Helen Kennelly; Jennifer M Corbett; Fiona Carty; Laura A Cahill; Máire Callaghan; Karen English; Bernard P Mahon; Sean Doyle; Minu Shinoy
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 2.  Aging and injury: alterations in cellular energetics and organ function.

Authors:  Ninu Poulose; Raghavan Raju
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

3.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment.

Authors:  Siobhán McClean
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

5.  Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.

Authors:  Uri Obolski; José Lourenço; Craig Thompson; Robin Thompson; Andrea Gori; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

Review 6.  Nanoparticle approaches against bacterial infections.

Authors:  Weiwei Gao; Soracha Thamphiwatana; Pavimol Angsantikul; Liangfang Zhang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-07-15

7.  An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.

Authors:  Lingbing Kong; Balakumar Vijayakrishnan; Michael Kowarik; Jin Park; Alexandra N Zakharova; Larissa Neiwert; Amirreza Faridmoayer; Benjamin G Davis
Journal:  Nat Chem       Date:  2016-02-01       Impact factor: 24.427

Review 8.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

Review 9.  Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance.

Authors:  Kun Shi; Shane J Caldwell; Desiree H Fong; Albert M Berghuis
Journal:  Front Cell Infect Microbiol       Date:  2013-06-25       Impact factor: 5.293

10.  Synthetic Immunobiotics: A Future Success Story in Small Molecule-Based Immunotherapy?

Authors:  Mary J Sabulski Feigman; Marcos M Pires
Journal:  ACS Infect Dis       Date:  2018-02-16       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.